Connor, Clark & Lunn Investment Management (CC&L)
AXSM icon

Connor, Clark & Lunn Investment Management (CC&L)’s Axsome Therapeutics AXSM Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$23.5M Buy
2025
Q1 		$20.5M Buy
2024
Q4 		$6.22M Buy
2024
Q1 		– Sell
2023
Q4 		$1.14M Buy
2022
Q2 		– Sell
2022
Q1 		$381K Buy